Harnessing multi-omics and AI for atherosclerotic cardiovascular disease management

Despite considerable life-saving progress, cardiovascular diseases (CVDs) remain the leading cause of death globally, claiming an estimated 17.9 million lives each year.

Biomind Labs Completes the Development of the First 5-MeO-DMT Organic Synthesis Scheme for Pharmaceutical Applications | Psychedelic Invest

Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals

September 14, 2023

AstraZeneca launches GLP-1 combo to treat obesity co-morbidities

Share this article AstraZeneca has announced its strategy for the cardiometabolic market, in particular for treating obesity. Credit: encierro via Shutterstock. AstraZeneca has announced its

November 14, 2023

Falling folate levels sound alarm for urgent UK food fortification

A study from the University of Cambridge used UK National Diet and Nutrition Survey data from 2008-2019 to examine folate levels, particularly in females of

October 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.